Brandon Kier

Title: The Innovations of Brandon Kier

Introduction

Brandon Kier is an accomplished inventor based in Lebanon, NH (US). He has made significant contributions to the field of biotechnology, particularly in the development of affinity agents for adeno-associated viruses. His work is characterized by a commitment to advancing scientific knowledge and practical applications in the industry.

Latest Patents

Brandon Kier holds 1 patent for his invention titled "AAV9 affinity agents." This patent provides detailed information about affinity agents that comprise ligands specifically designed to bind adeno-associated viruses. The affinity agents are instrumental in the binding, isolation, and purification of these viruses. Additionally, the patent discloses amino acid sequences of binding motifs or polypeptides included in the ligands, along with associated modifications and methods for creating these affinity agents.

Career Highlights

Brandon Kier is currently employed at Avitide LLC, a company known for its innovative solutions in bioprocessing. His role at Avitide allows him to apply his expertise in developing cutting-edge technologies that enhance the efficiency of biopharmaceutical production. His contributions have positioned him as a valuable asset in the field.

Collaborations

Throughout his career, Brandon has collaborated with notable colleagues, including William Scott Dodson and Brandon Coyle. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Brandon Kier's work exemplifies the spirit of innovation in biotechnology. His patent on AAV9 affinity agents showcases his dedication to advancing the field and improving biopharmaceutical processes. His contributions continue to have a lasting impact on the industry.